Systemic administration of PTEN attenuated arthritis severity in CIA mice, and an increased expression of PTEN curtailed T-cell activation and ameliorated the imbalance between Th17 cells and Tregs (200). The gene discussed is PTEN; the disease is arthritic joint disease.